Rosivo closes seed-round paving the path for commercialization of patented cartilage implant technology
IONIQ Sciences, Inc. announced it has been awarded “Most Innovative Non-Invasive Lung Cancer Testing Solution” and “Best Medical Technology Company 2021” by Global 100.
Powerful combination of key patents comes as the Company looks ahead to topline results from a Phase 3 registration study in ALS in second half of 2022.
Clene presented data from the RESCUE-ALS Phase 2 study of CNM-Au8®, a catalytically active gold nanocrystal suspension, for the treatment of amyotrophic lateral sclerosis (ALS).
Arena Pharmaceuticals, Inc. and Pfizer Inc. have entered into a definitive agreement under which Pfizer will acquire Arena.
The artificial-intelligence-powered drug designer Recursion signed on to a wide-ranging collaboration with Roche and its Genentech division.
For the fourth consecutive year, Utah Business magazine has honored ARUP Laboratories with its Best Companies to Work For Award.
Renalytix reported financial results for the quarter ended September 30, 2021.
The deal, worth several billion dollars, is a future-looking model of technology-enabled target and drug discovery
Use of latest Recursion inference technologies to expand exploration of fibrosis and may extend the collaboration to more than a dozen programs in total.
Co-Diagnostics announced that CoSara Diagnostics Pvt Ltd has received clearance by the Central Drugs Standard Control Organization (CDSCO) in India to manufacture and sell its SARAPLEX™ Flu A/Flu B/COVID-19 (ABC) RT-PCR test as an in vitro diagnostic (IVD).
Foldax announces that the Drugs Controller General of India (DCGI) has approved initiation of a clinical trial of the TRIA™ biopolymer surgical aortic heart valve.